| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 04/16/2009 | WO2006125165A3 Methods and compositions facilitating entry of compounds into cells |
| 04/16/2009 | WO2006122187A3 Treating and evaluating inflammatory disorders |
| 04/16/2009 | WO2006116681A3 Tat-003 and methods of assessing and treating cancer |
| 04/16/2009 | WO2006112925A3 Cxcr3 is a gliadin receptor |
| 04/16/2009 | WO2006099620A3 Rage/diaphanous interaction and related compositions and methods |
| 04/16/2009 | WO2006098793A3 Hslim modulates immune responses |
| 04/16/2009 | WO2006091930A3 Methods and compounds for promoting vessel regression |
| 04/16/2009 | WO2006089095A3 Treating neurological disorders |
| 04/16/2009 | WO2006083276A3 Interferon-alpha polypeptides and conjugates |
| 04/16/2009 | WO2006074179A3 Blockade of elr+cxc chemokines as a treatment for inflammatory and autoimmune disease |
| 04/16/2009 | WO2006060021A3 Bifunctional fusion proteins containing the flt3 ligand |
| 04/16/2009 | WO2006041829A3 Antagonist peptides to the c5a chemotactic function of vitamin d binding protein |
| 04/16/2009 | WO2006016282A3 Media indexer |
| 04/16/2009 | WO2006009676A3 Compositions and methods for enzymatic decolorization of chlorophyll |
| 04/16/2009 | WO2005118787A3 Method of screening candidate compounds for susceptibility to biliary excretion |
| 04/16/2009 | WO2005107364A3 Polynucleotide, polypeptides, and diagnostic methods |
| 04/16/2009 | WO2005084116A3 Calcium channel variants |
| 04/16/2009 | WO2005069994A3 Folate conjugates and complexes |
| 04/16/2009 | WO2005040356A3 Mutant p53 protein and uses thereof |
| 04/16/2009 | WO2005035714A3 Vaccines for cancer, autoimmune disease and infections |
| 04/16/2009 | WO2005016414A3 Use of receptor sequences for immobilizing gene vectors on surfaces |
| 04/16/2009 | WO2004074433A3 Rag polypeptides, nucleic acids, and their use |
| 04/16/2009 | WO2004039956A3 Compositions and methods for the treatment of immune related diseases |
| 04/16/2009 | US20090100551 Plant Seed Specific Promoters |
| 04/16/2009 | US20090100547 Plants with improved morphogenesis and method of constructing the same |
| 04/16/2009 | US20090100546 Plants with improved morphogenesis and method of constructing the same |
| 04/16/2009 | US20090100541 Transcription Factor Stress-Related Proteins and Methods of Use in Plants |
| 04/16/2009 | US20090100540 Transgenic plant cell comprising expression vector coding regulatory protein for use in enhancement of drought resistant plants |
| 04/16/2009 | US20090100535 nucleic acids encoding a chimeric protein comprising a cleavage domain and a composite nucleic acid-binding region, that comprises at least two component polypeptide portions which are individually capable of binding specific nucleotide sequences |
| 04/16/2009 | US20090100534 Muscle lamin a/c interacting protein, gene encoding same, and uses therefor |
| 04/16/2009 | US20090099826 Caspase-9:bir3 domain of xiap complexes and methods of use |
| 04/16/2009 | US20090099533 Virus derived antimicrobial peptides |
| 04/16/2009 | US20090099377 Production of increased oil and protein in plants by the disruption of the phenylpropanoid pathway |
| 04/16/2009 | US20090099338 Novel Protein Highly Producing Recombinant Animal Cell, Method for Preparing the Same, and Method for Mass-Producing Protein Using the Same |
| 04/16/2009 | US20090099337 S-nitroso group-containing albumin, method for production, and anticancer agent |
| 04/16/2009 | US20090099336 using the conjugates in the inhibition of cell growth; cancer; monoclonal antibody or epitope-binding fragment thereof, that recognizes and binds the CA6 glycotope |
| 04/16/2009 | US20090099268 Anti-adhesion membrane |
| 04/16/2009 | US20090099107 Methods and Compositions for Inhibition of Nuclear Factor kappaB |
| 04/16/2009 | US20090099090 Of given sequence; human leukocyte antigen; induce cytotoxic T cells; use of them as cancer vaccines, and methods for treatment and prevention of cancers based on them |
| 04/16/2009 | US20090099089 administering to the site of the full thickness defect of articular cartilage, an osteochondral graft , an active growth factor e.g. purified bone morphogenetic protein (BMP) and a suitable carrier for the regeneration of the cartilage |
| 04/16/2009 | US20090099086 Activin-ActRIIa antagonists and uses for promoting bone growth |
| 04/16/2009 | US20090099085 Amylin Derivatives |
| 04/16/2009 | US20090099083 Compositions for eliciting an immune response against mycobacterium avium subspecies paratuberculosis |
| 04/16/2009 | US20090099081 Synthetic axmi-004 delta-endotoxin genes and methods for their use |
| 04/16/2009 | US20090099080 Mitochondria-targeted anti-tumor agents |
| 04/16/2009 | US20090099079 Novel Fungal Enzymes |
| 04/16/2009 | US20090099078 Nogo Receptor Antagonists |
| 04/16/2009 | US20090099076 OBG3 Globular Head and Uses Thereof |
| 04/16/2009 | US20090099075 Chimeric Keratin-Binding Effector Proteins |
| 04/16/2009 | US20090099073 Albumin Fusion Proteins |
| 04/16/2009 | US20090099071 Sugar chain-containing albumin, production method thereof and use thereof |
| 04/16/2009 | US20090099068 On-growth inhibiting compounds |
| 04/16/2009 | US20090099067 Glycosylated with galactose-N-acetylgalactosamine; used for the introduction of exogenous nucleic acid sequences into the genome of avians in order to express the exogenous sequences to alter the phenotype of the avians or to produce desired proteins |
| 04/16/2009 | US20090099065 Acylated Single Chain Insulin |
| 04/16/2009 | US20090099064 Derivatized insulin oligomers |
| 04/16/2009 | US20090099063 Ssx-2 peptides presented by hla class ii molecules |
| 04/16/2009 | US20090099033 In vitro screening and evolution of proteins |
| 04/16/2009 | US20090099028 Protein binding miniature proteins and uses thereof |
| 04/16/2009 | US20090098650 Compositions for the in vitro derivation and culture of embryonic stem (es) cell lines with germline transmission capability and for the culture of adult stem cells |
| 04/16/2009 | US20090098636 Fungal cell wall synthesis gene |
| 04/16/2009 | US20090098634 Scleroprotein of an adeno associated virus with modified chromatographic properties, the production thereof and use of the same |
| 04/16/2009 | US20090098633 HMGN2 peptides and related molecules that selectively home to tumor blood vessels and tumor cells |
| 04/16/2009 | US20090098629 Comprises urogenital system specific protein for diagnosing and treating tumors; antiproliferative agents; genetic vaccine; 22P4F11 transcript and/or protein represent a useful diagnostic marker and/or therapeutic target for prostate cancer |
| 04/16/2009 | US20090098627 wherein mutant hydrolase forms stable bond with rhodococcus dehalogenase substrate; beta-lactamases; fusion proteins; cell labelling; tissue target therapy |
| 04/16/2009 | US20090098622 Schizochytrium pks genes |
| 04/16/2009 | US20090098609 Il-2 fusion proteins with modulated selectivity |
| 04/16/2009 | US20090098606 Cultivating mutant Bacillus licheniformis cell transformed with nucleic acid construct comprising nucleic acid directing synthesis of heterologous protein in suitable medium, where mutant cell comprises deletion mutation in cypX gene or yvmC gene in which mutation renders cell deficient in red pigment |
| 04/16/2009 | US20090098605 MUTATED TRUNCATED mt-pfkA GENE FOR THE SYNTHESIS OF ACTIVE SHORTER FRAGMENT OF 6-PHOSPHOFRUCTO-1-KINASE |
| 04/16/2009 | US20090098604 host cells; tumor antigens; for treatment, prevention of cancer |
| 04/16/2009 | US20090098603 Polypeptides sharing sequence identity with a fibroblast growth factor polypeptide and nucleic acids encoding the same |
| 04/16/2009 | US20090098599 Adenovirus vectors, packaging cell lines, compositions, and methods for preparation and use |
| 04/16/2009 | US20090098596 Photostable fret-competent biarsenical-tetracysteine probes based on fluorinated fluoresceins |
| 04/16/2009 | US20090098592 Method |
| 04/16/2009 | US20090098580 Mammalian sweet taste receptors |
| 04/16/2009 | US20090098579 Using g-protein coupled receptor as tools in identifying modulators which improve palatability of low-calorie beverages through development of new artificial sweeteners; modulating taste perception |
| 04/16/2009 | US20090098578 Asbestos detection method, asbestos detection agent, asbestos detection kit, method for screening candidate for agent aiming at preventing or treating disease for which asbestos is causative or worsening factor |
| 04/16/2009 | US20090098573 for use in designing and/or identifying modulators of insect behavior; biolgical pest control |
| 04/16/2009 | US20090098571 Methods and substances for the diagnosis and therapy of sepsis and sepsis-like systemic infections |
| 04/16/2009 | US20090098570 Lxr ligand testing method |
| 04/16/2009 | US20090098569 Novel PGC-1 Isoforms and Uses Therefor |
| 04/16/2009 | US20090098565 MeCP2E1 gene |
| 04/16/2009 | US20090098556 Genetic Test For PSE-Susceptible Turkeys |
| 04/16/2009 | US20090098554 Method and composition for cancer diagnosis and treatment |
| 04/16/2009 | US20090098546 Methods of Screening for LTRPC7 Modulators |
| 04/16/2009 | US20090098544 Marker molecules associated with lung tumors |
| 04/16/2009 | US20090098528 Method for determining early HCV seroconversion |
| 04/16/2009 | US20090098197 Cancer vaccine comprising a cancer antigen based on the product of a tumor suppressor gene wt1 and a cationic liposome |
| 04/16/2009 | US20090098176 Medical devices with triggerable bioadhesive material |
| 04/16/2009 | US20090098175 Methods and compositions for delivery of growth factor to fibrous connective tissue |
| 04/16/2009 | US20090098167 PHL P 1 Allergen Derivative |
| 04/16/2009 | US20090098166 Chimeric MSP-based malaria vaccine |
| 04/16/2009 | US20090098164 Spore associated display |
| 04/16/2009 | US20090098161 removal of structural features of HIV that interfere with immune response. In particular, sialic acid is removed to enhance immune recognition and to impair Complement Factor H binding, CD55 and CD59 removal prevent the binding of Complement Factor H; Acquired Immunodeficiency Syndrome |
| 04/16/2009 | US20090098160 sialic acid is removed to enhance immune recognition and to impair Complement Factor H binding; CD55 and CD59 removal prevents the binding of Complement Factor H; Acquired Immunodeficiency Syndrome |
| 04/16/2009 | US20090098153 Activation of HCV-specific T cells |
| 04/16/2009 | US20090098149 Transgenic algae for delivering antigens to an animal |
| 04/16/2009 | US20090098132 Composition and method for treating lupus nephritis |
| 04/16/2009 | US20090098131 Compositions and methods for the treatment of immune related diseases |
| 04/16/2009 | US20090098129 Member of the TNF Ligand Family |
| 04/16/2009 | US20090098128 NPC1L1 orthologues |